Financials

	CurrentMar 10, 2026	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	72.25M	92.50M	—	—
Enterprise Value	55.85M	89.18M	—	—
Last Close Price	28.90	37.00	—	—
Valuation Multiples
PE Ratio	14.12	19.35	—	—
PS Ratio	3.60	4.66	—	—
PB Ratio	2.39	3.20	—	—
P/TBV Ratio	2.39	3.20	—	—
P/FCF Ratio	20.25	17.55	—	—
P/OCF Ratio	18.81	16.87	—	—
EV/Sales Ratio	2.78	4.49	—	—
EV/EBITDA Ratio	8.99	14.75	—	—
EV/EBIT Ratio	11.09	17.43	—	—
EV/FCF Ratio	15.65	16.92	—	—
Leverage & Capital
Debt / Equity Ratio	0.06	0.06	0.13	0.36
Debt / EBITDA Ratio	0.27	0.29	0.35	0.51
Debt / FCF Ratio	0.48	0.34	—	0.58
Net Debt / Equity Ratio	-0.54	-0.57	-0.12	-0.42
Net Debt / EBITDA Ratio	-2.75	-2.72	-0.34	-0.67
Net Debt / FCF Ratio	-4.60	-3.12	1.01	-0.69
Efficiency & Liquidity
Asset Turnover	0.74	0.77	1.08	—
Inventory Turnover	4.88	6.51	9.06	—
Quick Ratio	14.69	11.51	2.64	1.39
Current Ratio	17.76	12.94	3.81	1.69
Returns & Yields
Return on Equity (ROE)	+20.4%	+22.1%	+38.3%	—
Return on Assets (ROA)	+11.5%	+12.3%	+16.2%	—
Return on Invested Capital (ROIC)	+34.3%	+38.6%	+50.3%	+84.9%
Return on Capital Employed (ROCE)	+15.2%	+16.2%	+25.4%	+35.5%
Earnings Yield	+6.5%	+5.2%	—	—
FCF Yield	+4.9%	+5.7%	—	—
Dividend Yield	—	+4.1%	—	—
Payout Ratio	+64.0%	+62.8%	+23.1%	—
Buyback Yield / Dilution	-31.7%	-38.4%	—	—
Total Shareholder Return	-31.7%	-34.3%	—	—

BALSM MEDICAL

Balsm Alofoq Medical Company

9620StocksTadawulHealthcareMarket closed

SAR 28.90

Official close

0.0%

Price as of March 29, 2026 · Market close

Prices may be delayed by up to 30 minutes.

	CurrentMar 10, 2026	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	72.25M	92.50M	—	—
Enterprise Value	55.85M	89.18M	—	—
Last Close Price	28.90	37.00	—	—
Valuation Multiples
PE Ratio	14.12	19.35	—	—
PS Ratio	3.60	4.66	—	—
PB Ratio	2.39	3.20	—	—
P/TBV Ratio	2.39	3.20	—	—
P/FCF Ratio	20.25	17.55	—	—
P/OCF Ratio	18.81	16.87	—	—
EV/Sales Ratio	2.78	4.49	—	—
EV/EBITDA Ratio	8.99	14.75	—	—
EV/EBIT Ratio	11.09	17.43	—	—
EV/FCF Ratio	15.65	16.92	—	—
Leverage & Capital
Debt / Equity Ratio	0.06	0.06	0.13	0.36
Debt / EBITDA Ratio	0.27	0.29	0.35	0.51
Debt / FCF Ratio	0.48	0.34	—	0.58
Net Debt / Equity Ratio	-0.54	-0.57	-0.12	-0.42
Net Debt / EBITDA Ratio	-2.75	-2.72	-0.34	-0.67
Net Debt / FCF Ratio	-4.60	-3.12	1.01	-0.69
Efficiency & Liquidity
Asset Turnover	0.74	0.77	1.08	—
Inventory Turnover	4.88	6.51	9.06	—
Quick Ratio	14.69	11.51	2.64	1.39
Current Ratio	17.76	12.94	3.81	1.69
Returns & Yields
Return on Equity (ROE)	+20.4%	+22.1%	+38.3%	—
Return on Assets (ROA)	+11.5%	+12.3%	+16.2%	—
Return on Invested Capital (ROIC)	+34.3%	+38.6%	+50.3%	+84.9%
Return on Capital Employed (ROCE)	+15.2%	+16.2%	+25.4%	+35.5%
Earnings Yield	+6.5%	+5.2%	—	—
FCF Yield	+4.9%	+5.7%	—	—
Dividend Yield	—	+4.1%	—	—
Payout Ratio	+64.0%	+62.8%	+23.1%	—
Buyback Yield / Dilution	-31.7%	-38.4%	—	—
Total Shareholder Return	-31.7%	-34.3%	—	—